Blurbs

Analysts Conflicted on These Technology Names: Palo Alto Networks (PANW), Viavi Solutions (VIAV) and Accolade (ACCD)

Analysts have been eager to weigh in on the Technology sector with new ratings on Palo Alto Networks (PANWResearch Report), Viavi Solutions (VIAVResearch Report) and Accolade (ACCDResearch Report).

Palo Alto Networks (PANW)

In a report released today, Hamza Fodderwala from Morgan Stanley maintained a Buy rating on Palo Alto Networks, with a price target of $274.33. The company’s shares closed last Tuesday at $548.88.

According to TipRanks.com, Fodderwala is a 1-star analyst with an average return of -4.9% and a 42.0% success rate. Fodderwala covers the Technology sector, focusing on stocks such as CrowdStrike Holdings, CyberArk Software, and Tenable Holdings.

Palo Alto Networks has an analyst consensus of Strong Buy, with a price target consensus of $212.80, representing a -61.6% downside. In a report issued on September 6, FBN Securities also maintained a Buy rating on the stock with a $72.21 price target.

See today’s best-performing stocks on TipRanks >>

Viavi Solutions (VIAV)

Morgan Stanley analyst Meta Marshall maintained a Hold rating on Viavi Solutions today and set a price target of $17.00. The company’s shares closed last Tuesday at $14.14.

According to TipRanks.com, Marshall is a 4-star analyst with an average return of 5.4% and a 56.5% success rate. Marshall covers the Technology sector, focusing on stocks such as Zoom Video Communications, Keysight Technologies, and KORE Group Holdings.

The word on The Street in general, suggests a Hold analyst consensus rating for Viavi Solutions with a $17.00 average price target, implying a 16.4% upside from current levels. In a report released today, Needham also maintained a Hold rating on the stock.

Accolade (ACCD)

In a report released today, Ricky Goldwasser from Morgan Stanley maintained a Hold rating on Accolade, with a price target of $12.00. The company’s shares closed last Tuesday at $12.11.

According to TipRanks.com, Goldwasser is a 5-star analyst with an average return of 14.0% and a 64.7% success rate. Goldwasser covers the Healthcare sector, focusing on stocks such as AmerisourceBergen, Elevance Health, and Cardinal Health.

Currently, the analyst consensus on Accolade is a Moderate Buy with an average price target of $12.25.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PANW:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos